Contacts Andrew D. Regrut Vice President, Investor Relations 812.827.4151 Investor.Relations@kimballelectronics.com Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for...
REDWOOD CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on...
DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the innovative luxury travel club,...
Results in-line with Expectations; Reaffirms 2024 Sales and Earnings Guidance Contacts Inter Parfums, Inc. Michel Atwood Chief Financial Officer (212)...
BETHESDA, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest...
ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (Nasdaq: GTX) (the “Company”) announced today that Garrett Motion...
Contacts Green Plains Inc. Contacts Investors: Phil Boggs | Executive Vice President, Investor Relations & Finance | 402.884.8700 | phil.boggs@gpreinc.com...
Contacts Vince Arnone President and CEO (630) 845-4500 Devin Sullivan Managing Director The Equity Group Inc. dsullivan@equityny.com Fuel Tech, Inc....
CLEARWATER, FL / ACCESSWIRE / May 7, 2024 / Fortune Rise Acquisition Corporation (Nasdaq:FRLA) ("FRLA" or the "Company") today announced...
Contacts Investor and Media Contact: Naresh Tanna Vice President of Investor Relations naresh.tanna@precisionbiosciences.com Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced...
CUPERTINO, Calif., May 7, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies...
Montrouge, France, le 7 mai DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur...
Procedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial...
- Total Revenue Growth of 15% to $380.4 Million; Organic Revenue Growth(1) of 16% - - Net Income of $39.1...
WARREN, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful...
Contacts For investor and media inquiries, please contact: Steven Pelayo, CFA The Blueshirt Group steven@blueshirtgroup.co +1 (360) 808-5154 Alpha and...
Not for distribution to United States Newswire Services or for dissemination in the United StatesTORONTO, May 07, 2024 (GLOBE NEWSWIRE)...
GAITHERSBURG, Md., May 7, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global...
LITTLE ROCK, Ark., May 07, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President...
Grows Revenue 3.0% and Opens STK Washington DC During the Quarter Completed Acquisition of Safflower Holdings Corp., the Owner of...
EAST HANOVER, NJ / ACCESSWIRE / May 7, 2024 / SilverSun Technologies, Inc. (NASDAQ:SSNT), a national provider of transformational business...
Company reports solid first half, on-track to achieve Fiscal 2024 guidance Contacts Investor Contact James Baglanis IR@sonos.com Press Contact Erin...
Conference call to be conducted on Tuesday, May 14, 2024, at 11:00AM ET LONGMONT, Colo., May 7, 2024 /PRNewswire/ --...
Phase 1 MYTHIC clinical trial of lunresertib in combination with camonsertib demonstrated a significant reduction in Grade 3 anemia and...
Significant steps being taken to drive greater capital efficiency Company reiterates path to Q4 2024 modest gross profit During Q1...
AMESBURY, Mass., May 7, 2024 /PRNewswire/ -- Provident Bancorp, Inc. (NASDAQ: PVBC) (the "Company"), the holding company for BankProv (the...
Entered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027 Enrollment in...
Contacts Investor Contacts: Pulse Biosciences Kevin Danahy, President and CEO 510.241.1077 IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com...
First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 First quarter 2024 net income of...
SAN DIEGO, May 7, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the BofA Securities 2024 Health...
DALLAS, May 7, 2024 /PRNewswire/ -- Match Group (NASDAQ: MTCH) posted its first quarter 2024 shareholder letter on the investor...
MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today reported financial...
EFFINGHAM, Ill., May 07, 2024 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of...
UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, das Unternehmen, wir oder unser),...
Contacts Investor Contact: Andrew McKibben investors@mirumpharma.com Media Contact: Erin Murphy media@mirumpharma.com Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused...
Results for the Quarter Ended March 31, 2024 and Other Recent Highlights:NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- MidCap Financial...
Q1 OverviewDALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial...
Q1 OverviewDALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial...
Q1 Rides and Gross Bookings Growth Exceed 20% Year-Over-Year Expects Higher Cash Generation for Full-Year 2024 Contacts Sonya Banerjee investor@lyft.com...
JOHANNESBURG, South Africa, May 07, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka”) has signed a...
